Delivery Order SPE2DB24D8001-SPE2DB24FKZCB
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,006.26 to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide Aimovig 140 mg/mL autoinjectors. This contract has a completion date of February 5, 2025 and is not set-aside. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The company holds a...
This is a $1,532.07 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of AIMOVIG 70 MG/ML autoinjectors, a pharmaceutical product, with a performance period through November 25, 2024. This award is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop...
This is a $3,035.10 firm fixed-price delivery order (SPE2DX15D8003|SPE2DX24F7C7D) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through February 12, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
This federal contract award, valued at $4,370.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. This appears to be a stand-alone delivery order contract, not associated with a larger contract vehicle. The contract has a firm fixed-price pricing structure and does not utilize a...
This firm fixed-price delivery order contract was awarded by the Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical, to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,717.38, is for the supply of the prescription medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024...
The federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNJF, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,993.04, is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a performance period ending on March 20, 2025. The contract is not set-aside and is part of a larger Indefinite...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
The Defense Logistics Agency Troop Support Medical awarded a $1,099.52 firm fixed price delivery order to Dakota Drug, Inc. of Minot, North Dakota. The order is for 140 mg/ml Aimovig autoinjectors to be delivered between September 19-20, 2023. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. No subcontractors or set aside designations were indicated. The short duration and item description suggest this order is to fulfill...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a Delivery Order valued at $2,397.84 for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly supporting U.S. Armed...
This federal contract award, valued at $2,902.10, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order under the DLA's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. valued at $999,999,999.00. The contract is for the delivery of pharmaceutical products, specifically Dupixent 300 mg/2 ml pens, to support U.S. Armed Forces medical operations. As a key...